# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Central Nervous System Lymphoma, Primary

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 46 results.
Venetoclax and Obinutuzumab for Relapsed Primary CNS Lymphoma
Status: Recruiting
Last Changed: Jul 28, 2020
First Received: Aug 29, 2019
Disease(s): Primary CNS Lymphoma
Intervention(s): Venetoclax, Obinutuzumab
Locations: Klinikum Stuttgart, Stuttgart, Baden-Württemberg, Germany
[CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma
Status: Recruiting
Last Changed: May 24, 2019
First Received: Jun 26, 2018
Disease(s): Primary CNS Lymphoma
Intervention(s): Rituximab, Methotrexate, Cytarabine
Locations: Samsung Medical Center, Seoul, Gangnam-gu,, Korea, Republic of
Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
Status: Recruiting
Last Changed: Apr 24, 2020
First Received: Feb 17, 2006
Disease(s): Central Nervous System Lymphoma
Intervention(s): Carboplatin, Laboratory Biomarker Analysis, Mannitol, Methotrexate, Quality-of-Life Assessment, Rituximab, Sodium Thiosulfate
Locations: Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
OHSU Knight Cancer Institute, Portland, Oregon, United States
A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Status: Recruiting
Last Changed: Oct 17, 2019
First Received: Oct 17, 2019
Disease(s): Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL)
Intervention(s): Ibrutinib, Lenalidomide, Methotrexate, Rituximab, Etoposide, PEGylated recombinant human granulocyte colony
Locations: Department of Hematology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China/Zhejiang Province, China
R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL:a Multicenter Phase Ib/II Stuty
Status: Recruiting
Last Changed: Jun 05, 2020
First Received: Oct 09, 2019
Disease(s): Primary Central Nervous System Lymphoma
Intervention(s): Methotrexate, Rituximab, Lenalidomide
Locations: Daobin Zhou, Beijing, Dongcheng District, China
LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma - ARM A
Status: Recruiting
Last Changed: May 13, 2020
First Received: Sep 26, 2018
Disease(s): Central Nervous System Lymphoma
Intervention(s): Voraxaze, Methotrexate, Rituximab, leucovorin
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Memorial Sloan Kettering Commack, Commack, New York, United States
... and 4 other locations.
Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost
Status: Recruiting
Last Changed: Aug 28, 2019
First Received: Jul 05, 2019
Disease(s): Primary CNS Lymphoma, Brain Lymphoma
Intervention(s): A treatment protocol of combined chemoradiation delivered in the manner of hyperfractionated conformal whole-brain radiation therapy
Locations: Chang Gung Memorial Hospital, Taoyuan, Taiwan
IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL
Status: Not yet recruiting
Last Changed: Aug 26, 2019
First Received: Aug 26, 2019
Disease(s): Primary Central Nervous System Lymphoma
Intervention(s): IBER salvage chemotherapy followed by ibrutinib maintenance therapy
Locations: Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Korea, Republic of
Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma
Status: Recruiting
Last Changed: Aug 20, 2019
First Received: Dec 10, 2014
Disease(s): Primary Central Nervous System Lymphoma
Intervention(s): Rituximab, Methotrexate, Temozolomide
Locations: Groupe Hospitalier Pitie Salpetriere, Paris, France
Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute
Status: Recruiting
Last Changed: Jan 30, 2019
First Received: Jan 14, 2016
Disease(s): Primary Central Nervous System Lymphoma
Intervention(s): Standard treatment protocol with combined chemoradiation
Locations: Chang Gung Memorial Hospital, Taoyuan, Taiwan